Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The British approach to cholesterol: A reason for lower health costs

Richard Young, MD
Meds
November 27, 2013
Share
Tweet
Share

The American Heart Association and American College of Cardiology recently published new guidelines for screening and treating cholesterol.

In some ways these guidelines are more like the British guidelines. Instead of setting up doctors and patients to fail by calling for certain cholesterol number targets as in the old U.S. guidelines (i.e. LDL level below 100), they instead focus on putting higher risk patients on drugs called statins and then not worrying about the new cholesterol number under treatment. It’s more simply: high risk, take statin; low risk, don’t take statin.

Of course these guidelines don’t come without controversy. Some estimate the number of adults recommended to take statins will double. Others criticize the spreadsheet that comes with the guidelines as exaggerating the true risk of developing heart disease by 75% to 150%.

The other factor that has gotten less press is the definition of high risk, even if the heart disease calculator is accurate. The AHA/ACC definition of high risk is a greater than 7.5% of developing symptomatic heart disease (not death) in 10 years. The British define high risk as a 20% chance in 10 years.

This is clearly a huge difference and it speaks to the underlying cultures of the two countries. The U.S. doctors and the large foundation that supports them err on the side of assuming more is better, and any theoretical benefit — no matter how high the cost — is worth it.

The British err on the side of being sure that the benefits of drug therapy is clearly greater than the risks of adverse events, and they take costs into consideration. Some people are simply at too low a risk to justify the expense and hassle of a lifetime of drugs.

I wrote earlier about explaining why screening and treating people for high cholesterol does not save money, even in the long run.

The British people and their government are willing to tell its healthcare industry that it can’t have everything it wants, and that other societal goods improve health as well. This is one of the many reasons the British people enjoy better health at less than half the cost of the U.S.

Richard Young is a physician who blogs at American Health Scare.

Prev

Will a personalized DNA report ever be commonly ordered?

November 27, 2013 Kevin 4
…
Next

Who do you want reading your EKG?

November 27, 2013 Kevin 17
…

Tagged as: Cardiology, Medications

Post navigation

< Previous Post
Will a personalized DNA report ever be commonly ordered?
Next Post >
Who do you want reading your EKG?

ADVERTISEMENT

More by Richard Young, MD

  • When medical protocol meets family concerns

    Richard Young, MD
  • Patients in Sweden received fewer post-op opioids. Why is that?

    Richard Young, MD
  • Medicine is too complex for computers to keep up with or understand

    Richard Young, MD

More in Meds

  • How CAR-NK cancer therapy could be safer than CAR-T

    Cliff Dominy, PhD
  • Psychedelic-assisted therapy: science, safety, and regulation

    Muhamad Aly Rifai, MD
  • The anticoagulant evidence controversy: a whistleblower’s perspective

    David K. Cundiff, MD
  • Is tramadol really ineffective and risky?

    John A. Bumpus, PhD
  • Unregulated botanical products: the hidden risks of convenience store supplements

    Muhamad Aly Rifai, MD
  • “The meds made me do it”: Unpacking the Nick Reiner tragedy

    Arthur Lazarus, MD, MBA
  • Most Popular

  • Past Week

    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why every physician needs a sabbatical (and how to take one)

      Christie Mulholland, MD | Physician
    • Retail health care vs. employer DPC: Preparing for 2026 policy shifts

      Dana Y. Lujan, MBA | Policy
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • The blind men and the elephant: a parable for modern pain management

      Richard A. Lawhern, PhD | Conditions
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
  • Recent Posts

    • The economics of prevention: Why an ounce is worth a pound

      Joshua Mirrer, MD | Conditions
    • Methamphetamine-induced lung injury: the hidden diagnosis in South Texas

      Shiv K. Goel, MD | Conditions
    • A 6-step framework for new health care leaders

      All Levels Leadership | Physician
    • The cost of ignoring pharmacist clinical judgment in health care

      Muhammad Abdullah Khan | Conditions
    • 10,000 steps before lunch: How a retired doctor models prevention

      Gerald Kuo | Conditions
    • Why health advocacy needs foresight and backcasting tools

      Dr. Lind Grant-Oyeye | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why every physician needs a sabbatical (and how to take one)

      Christie Mulholland, MD | Physician
    • Retail health care vs. employer DPC: Preparing for 2026 policy shifts

      Dana Y. Lujan, MBA | Policy
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • The blind men and the elephant: a parable for modern pain management

      Richard A. Lawhern, PhD | Conditions
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
  • Recent Posts

    • The economics of prevention: Why an ounce is worth a pound

      Joshua Mirrer, MD | Conditions
    • Methamphetamine-induced lung injury: the hidden diagnosis in South Texas

      Shiv K. Goel, MD | Conditions
    • A 6-step framework for new health care leaders

      All Levels Leadership | Physician
    • The cost of ignoring pharmacist clinical judgment in health care

      Muhammad Abdullah Khan | Conditions
    • 10,000 steps before lunch: How a retired doctor models prevention

      Gerald Kuo | Conditions
    • Why health advocacy needs foresight and backcasting tools

      Dr. Lind Grant-Oyeye | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The British approach to cholesterol: A reason for lower health costs
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...